Non-Fermenters - Emerging Health Care Pathogens

Aerobic nonfermenting gram-negative bacilli (nonfermenters) are a heterogeneous group of organisms that are either incapable of utilizing carbohydrates as a source of energy or degrade them via oxidative rather than fermentative pathway. These organisms are common inhabitants of soil and water. Nonfermenters can cause a vast variety of infections and account for approximately 15%of all Gram negative bacilli cultured from clinical specimens. Their infection are endogenous or exogenous origin, depending on several factor such as use of immunosuppressant substance, abusive use of wide spectrum antimicrobial agents, prolong surgical procedure and inadequate instrumentation. Pseudomonas cause endocarditis, osteomyelitis, urinary tract infections, gastrointestinal infections, meningitis, and, commonly septicaemia. Acinetobacter has emerged as an important nosocomial organism causing infectious outbreaks in critically ill patients leading to high mortality and morbidity. Burkholderia cepacia shows fast growth on immune-depleted patients - like cystic fibrosis patients (CFPs). Sphingomonas paucimobilis can produce biofilms or attach to preexisting biofilms, where they become integrated and survive for days. Most infections caused by nonfermenters have been nosocomial, often related to contamination of hospital equipment or fluids and have occurred in immunocompromised hosts. Non-fermenting Gram-negative bacilli are innately resistant to many antibiotics and are known to produced extrended spectrum β-lactmases and metallo β-lactmases. This review article highlights the different clinical conditions caused by the nonfermenters.

[1]  D. Stableforth,et al.  The Treatment of Respiratory Pseudomonas Infection in Cystic Fibrosis , 2000, Drugs.

[2]  Zhi-dong Hu,et al.  Detection of OXA‐type carbapenemases and integrons among carbapenem‐resistant Acinetobactor baumannii in a Teaching Hospital in China , 2011, Journal of basic microbiology.

[3]  V. Raia,et al.  Sphingobacterium respiratory tract infection in patients with cystic fibrosis , 2009, BMC Research Notes.

[4]  A. Malini,et al.  Nonfermenting Gram-Negative Bacilli Infections in a Tertiary Care Hospital in Kolar, Karnataka , 2009, Journal of laboratory physicians.

[5]  M. Vaneechoutte,et al.  Identification of non-fermenting Gram-negative bacteria of clinical importance by an oligonucleotide array. , 2009, Journal of medical microbiology.

[6]  C. Gerba,et al.  Risk assessment of Pseudomonas aeruginosa in water. , 2009, Reviews of environmental contamination and toxicology.

[7]  C. Stratton,et al.  Acinetobacter septicus sp. nov. Association with a Nosocomial Outbreak of Bacteremia in a Neonatal Intensive Care Unit , 2008, Journal of Clinical Microbiology.

[8]  Jong Moon Park,et al.  A Case of Postoperative Sphingomonas paucimobilis Endophthalmitis After Cataract Extraction , 2008, Korean journal of ophthalmology : KJO.

[9]  M. Willcox,et al.  Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. , 2007, Optometry and vision science : official publication of the American Academy of Optometry.

[10]  E. Dellinger,et al.  Necrotizing soft-tissue infection: diagnosis and management. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Luigi Chiarini,et al.  Burkholderia cepacia complex species: health hazards and biotechnological potential. , 2006, Trends in microbiology.

[12]  I. Vickers,et al.  The immunomodulatory effect of antibiotics on the secretion of tumour necrosis factor alpha by peripheral blood mononuclear cells in response to Stenotrophomonas maltophilia stimulation. , 2006, The West Indian medical journal.

[13]  P. Fournier,et al.  The epidemiology and control of Acinetobacter baumannii in health care facilities. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Bartlett,et al.  Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  N. Borrell,et al.  Sphingobacterium multivorum isolated from a patient with cystic fibrosis , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[16]  F. Huang,et al.  Neonatal sepsis in the neonatal intensive care unit: characteristics of early versus late onset. , 2004, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[17]  M. Martinez,et al.  Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces , 2003, Cellular microbiology.

[18]  L. Calza,et al.  Stenotrophomonas (Xanthomonas) maltophilia as an Emerging Opportunistic Pathogen in Association with HIV Infection: A 10-Year Surveillance Study , 2003, Infection.

[19]  M. Marinella Cellulitis and sepsis due to sphingobacterium. , 2002, JAMA.

[20]  D. Georgieva,et al.  The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia: characterization of the protein and molecular cloning of the gene. , 2002, The Journal of biological chemistry.

[21]  M. Salkinoja-Salonen,et al.  Characterization of Sphingomonas isolates from Finnish and Swedish drinking water distribution systems , 2000, Journal of applied microbiology.

[22]  D. Landman,et al.  Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. L. Moreira,et al.  Frequency of Nonfermentative Gram-Negative Bacilli Isolated from Clinical Materials of Pacients at Universidade Federal do Ceará Hospital Complex - Brazil , 1998 .

[24]  J. Heritage,et al.  Exceptional desiccation tolerance of Acinetobacter radioresistens. , 1998, The Journal of hospital infection.

[25]  C. Goodwin,et al.  Burn Wound Infections: Current Status , 1998, World Journal of Surgery.

[26]  A. Prince,et al.  Role of Flagella in Pathogenesis ofPseudomonas aeruginosa Pulmonary Infection , 1998, Infection and Immunity.

[27]  C. Bizet,et al.  Strains of Alcaligenes faecalis from clinical material. , 1997, The Journal of infection.

[28]  K. Carroll,et al.  Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients. , 1996, The Journal of infectious diseases.

[29]  F. Tekaia,et al.  In-vitro susceptibility of Alcaligenes faecalis compared with those of other Alcaligenes spp. to antimicrobial agents including seven beta-lactams. , 1993, The Journal of antimicrobial chemotherapy.

[30]  K. Nikaido,et al.  Identification and characterization of porins in Pseudomonas aeruginosa. , 1991, The Journal of biological chemistry.

[31]  J. Freney,et al.  Septicemia caused by Sphingobacterium multivorum , 1987, Journal of clinical microbiology.

[32]  P. Liu,et al.  Extracellular toxins of Pseudomonas aeruginosa. , 1974, The Journal of infectious diseases.